Liontos, M., Andrikopoulou, A., Koutsoukos, K., Markellos, C., Skafida, E., Fiste, O., . . . Zagouri, F. (2021). Neutrophil-to-lymphocyte ratio and chemotherapy response score as prognostic markers in ovarian cancer patients treated with neoadjuvant chemotherapy. BMC.
Cita Chicago Style (17a ed.)Liontos, M., et al. Neutrophil-to-lymphocyte Ratio and Chemotherapy Response Score as Prognostic Markers in Ovarian Cancer Patients Treated with Neoadjuvant Chemotherapy. BMC, 2021.
Cita MLA (8a ed.)Liontos, M., et al. Neutrophil-to-lymphocyte Ratio and Chemotherapy Response Score as Prognostic Markers in Ovarian Cancer Patients Treated with Neoadjuvant Chemotherapy. BMC, 2021.
Precaución: Estas citas no son 100% exactas.